Search for Clinical Trial Results

Lennox Gastaut Syndrome - 19 Studies Found
Status | Study |
Active, not recruiting |
Study Name: Post-marketing Surveillance of Long-term Administration of Inovelon Tablets in Patients With Lennox-Gastaut Syndrome Condition: Lennox-Gastaut Syndrome Date: 2014-06-10 Interventions: Drug: Rufinamide Administration of Inoveron 100mg or 200mg Tablets |
Completed |
Study Name: A Study to Investigate the Efficacy and Safety of Cannabidiol (GWP42003-P; CBD) as Adjunctive Treatment for Seizures Associated With Lennox-Gastaut Syndrome in Children and Adults Condition:
Date: 2014-08-21 Interventions:
|
Completed |
Study Name: A Long Term Extension Study of E2080 in Lennox-Gastaut Patients Condition: Lennox-Gastaut Syndrome Date: 2010-06-14 Interventions: Drug: E2080 The target dosage is approximately 45 mg/kg/day, taken orally twice a day. |
Completed |
Study Name: Add-on Therapy With Low Dose Fenfluramine in Lennox Gastaut Epilepsy Condition:
Date: 2016-01-12 Interventions: Drug: Fenfluramine study of efficacy and safety of add-on fenfluramine at different dosages in refractor |
Completed |
Study Name: A Study of the Efficacy and Safety of Topiramate as an add-on Therapy in the Treatment of Epilepsy Patients With Lennox-Gastaut Syndrome Condition:
Date: 2005-10-07 Interventions: Drug: topiramate |
Terminated |
Study Name: Long-term, Open-label Safety Extension Study of Retigabine/Ezogabine in Pediatric Subjects (>= 12 Years Old) With POS or LGS Condition: Epilepsy Date: 2012-05-17 Interventions: Drug: retigabine/ezogabine retigabine/ezogabine will be administered three times a day (TID) as add-on t |
Completed |
Study Name: Ketogenic Diet for Child Epilepsy and Seizure Control Condition:
|
Completed |
Study Name: A Study of the Safety of Topiramate Given in Combination With Other Medications in Adults and Children With Seizures Condition:
Date: 2006-02-24 Interventions: Drug: Topiramate Individualization of the treatment should begin from 25 mg for 1 week. |
Terminated |
Study Name: Study in Pediatric Subjects With Epilepsy Condition: Epilepsy Date: 2011-12-01 Interventions: Drug: ezogabine/retigabine ezogabine dose escalation |